Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Charlie's Holdings, Inc.TRUU · Entity 7095 | CEO AND CFO | July 05, 2018 | July 07, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Charlie's Holdings, Inc.
Report date July 05, 2018 · Filed July 07, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.07 · Expires 2022-09-29 | Direct | 0 |
Reported balance
After 2018-07-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2018-07-05 · Disposition to issuer · Disposed 3,937,706 · Balance 0 F1: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.03 · Expires 2023-01-30 | Direct | 3,937,706 |
Reported balance
After 2018-07-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-07-05 · Grant · Acquired 3,937,706 · Balance 3,937,706 F1: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.02 · Expires 2028-01-30 | Direct | 3,172,294 |
Reported balance
After 2018-07-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-07-05 · Grant · Acquired 3,172,294 · Balance 3,172,294 |
Filing footnotes · ownership attribution and instrument terms
F1: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 05, 2018 Filed Jul 7, 2018 01:54 UTC | Charlie's Holdings, Inc. TRUU · Entity 7095 | GrantStock Option · Derivative | 3,172,294 | $0.00 Strike: $0.02 | $0.00 |
DisclosureSEC source: 0001415889-18-001090 · form4-07062018_060756.xml · derivative · entry 3 VAN BOERUM ROBERT · CIK 0001655832 · CEO AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,172,294 Underlying: Common Stock · 3,172,294 shares Expires 2028-01-30 Read SEC document |
| July 05, 2018 Filed Jul 7, 2018 01:54 UTC | Charlie's Holdings, Inc. TRUU · Entity 7095 | GrantStock Option · Derivative | 3,937,706 | Not disclosed Strike: $0.03 | Not disclosed |
DisclosureSEC source: 0001415889-18-001090 · form4-07062018_060756.xml · derivative · entry 2 VAN BOERUM ROBERT · CIK 0001655832 · CEO AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,937,706 Underlying: Common Stock · 3,937,706 shares Expires 2023-01-30 F1 · kind: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · price: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · derivative.expiration_date: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. Read SEC document |
| July 05, 2018 Filed Jul 7, 2018 01:54 UTC | Charlie's Holdings, Inc. TRUU · Entity 7095 | Disposition to issuerStock Option · Derivative | 3,937,706 | Not disclosed Strike: $0.07 | Not disclosed |
DisclosureSEC source: 0001415889-18-001090 · form4-07062018_060756.xml · derivative · entry 1 VAN BOERUM ROBERT · CIK 0001655832 · CEO AND CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,937,706 shares Expires 2022-09-29 F1 · kind: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · price: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. F1 · derivative.expiration_date: The reported transaction involved the modification of certain outstanding options, resulting in the deemed cancellation of the "old" options and the grant of replacement options with a reduced exercise price of $0.025 per share and extended expiration date, which modifications were approved in advance by the Issuer's Board of Directors on January 30, 2018. The cancellation and subsequent grant were both exempt from Section 16(b) pursuant to Rule 16b-3(e) and Rule 16b-3(d), respectively. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.